Zhiyong Xu

机构：Guangzhou University of Chinese Medicine, The Fourth People's Hospital, Shanghai University of Traditional Chinese Medicine, Wuhan Institute of Technology · ORCID：0000-0002-7984-6054

发表论文 18 篇 · 总被引 429 次 · h-index 7

代表论文

• Radiation-induced liver disease in three-dimensional conformal radiation therapy for primary liver carcinoma: The risk factors and hepatic radiation tolerance (2006 · International Journal of Radiation Oncology*Biology*Physics · 被引 281)
• Application of active breathing control in 3-dimensional conformal radiation therapy for hepatocellular carcinoma: The feasibility and benefit (2008 · Radiotherapy and Oncology · 被引 47)
• Brain Metastases Status and Immunotherapy Efficacy in Advanced Lung Cancer: A Systematic Review and Meta-Analysis (2021 · Frontiers in Immunology · 被引 21)
• Novel SERCA2 inhibitor Diphyllin displays anti-tumor effect in non-small cell lung cancer by promoting endoplasmic reticulum stress and mitochondrial dysfunction (2024 · Cancer Letters · 被引 19)
• On the optimal number of dose‐limiting shells in the SBRT auto‐planning design for peripheral lung cancer (2020 · Journal of Applied Clinical Medical Physics · 被引 16)
• A novel IMRT planning study by using the fixed-jaw method in the treatment of peripheral lung cancer with mediastinal lymph node metastasis (2017 · Medical dosimetry · 被引 9)